BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 5096207)

  • 1. [Silymarin action in liver diseases].
    Hammerl H; Pichler O; Studlar M
    Med Klin; 1971 Sep; 66(36):1204-8. PubMed ID: 5096207
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antihepatotoxic influence of silymarin on galactosamine hepatitis in the rat].
    Meyer-Burg J
    Klin Wochenschr; 1972 Nov; 50(22):1062-3. PubMed ID: 4637662
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S; Gonvers JJ; Hofstetter JR
    Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
    [No Abstract]   [Full Text] [Related]  

  • 4. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 5. Normotest in acute hepatitis and chronic liver disease.
    Ockerman PA; Braconier JH; Eriksson O
    Scand J Gastroenterol Suppl; 1973; 19():83-91. PubMed ID: 4515643
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of serum argininosuccinate lyase (ASAL) concentrations as an index to parenchymal liver disease.
    Campanini RZ; Tapia RA; Sarnat W; Natelson S
    Clin Chem; 1970 Jan; 16(1):44-53. PubMed ID: 5414121
    [No Abstract]   [Full Text] [Related]  

  • 7. [Silymarin, a membranotropic drug: clinical and experimental observations].
    De Martiis M; Fontana M; Sebastiani F; Parenzi A
    Clin Ter; 1977 May; 81(4):333-62. PubMed ID: 880785
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 9. [The antihepatotoxic effect of silymarin on liver damage in rats induced by carbon tetrachloride, d-galactosamine and allyl alcohol].
    Rauen HM; Schriewer H
    Arzneimittelforschung; 1971 Aug; 21(8):1194-201. PubMed ID: 5110018
    [No Abstract]   [Full Text] [Related]  

  • 10. [The anti-hepatotoxic effect of parenterally administered silymarin in galactosamine hepatitis of the rat].
    Schriewer H; Rausen HM
    Arzneimittelforschung; 1973 Jan; 23():Suppl:159. PubMed ID: 4740687
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacodynamics, site and mechanism of action of silymarin, the antihepatoxic principle from Silybum mar. (L) Gaertn. 1. Acute toxicology or tolerance, general and specific (liver-) pharmacology].
    Vogel G; Trost W; Braatz R; Odenthal KP; Brüsewitz G; Antweiler H; Seeger R
    Arzneimittelforschung; 1975 Jan; 25(1):82-9. PubMed ID: 1173772
    [No Abstract]   [Full Text] [Related]  

  • 12. [Basis for the pathogenetic diet therapy of chronic liver diseases in children].
    Nevskaia TS; Pinzur ED; Zubrilina GV; Chistova LV
    Vopr Pitan; 1971; 30(2):50-5. PubMed ID: 5137214
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the protective efficacy of Asteracantha longifolia on acetaminophen-induced liver damage in rats.
    Shivashangari KS; Ravikumar V; Devaki T
    J Med Food; 2004; 7(2):245-51. PubMed ID: 15298774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of subacute and chronic forms of hepatitis as well as of chronic degenerative liver diseases using Silymarin].
    Zirm KL
    Wien Med Wochenschr; 1973 May; 123(19):302-5. PubMed ID: 4702588
    [No Abstract]   [Full Text] [Related]  

  • 15. [Assessment of liver function in various allergic dermatoses].
    Szarmach H; Kalas J; Bielawski W; Dratwiński Z
    Allerg Immunol (Leipz); 1972; 18(4):281-5. PubMed ID: 4274538
    [No Abstract]   [Full Text] [Related]  

  • 16. The behaviour of ceruloplasmin fractions in liver diseases.
    Trip JA; Que GS; Botterweg-Span Y; Mandema E
    Acta Med Scand; 1969 Apr; 185(4):279-86. PubMed ID: 5806337
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum iron levels in ostensibly normal people.
    Crosby WH; Likhite VV; O'Brien JE; Forman D
    JAMA; 1974 Jan; 227(3):310-2. PubMed ID: 4859659
    [No Abstract]   [Full Text] [Related]  

  • 18. Hematologic and clinical chemistry effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals.
    Zinkl JG; Vos JG; Moore JA; Gupta BN
    Environ Health Perspect; 1973 Sep; 5():111-8. PubMed ID: 4752897
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of prolonged halothane anesthesia on some cetaceans.
    Medway W; McCormick JG; Ridgway SH; Crump JF
    J Am Vet Med Assoc; 1970 Sep; 157(5):576-82. PubMed ID: 5452075
    [No Abstract]   [Full Text] [Related]  

  • 20. [A liver-specific antigen in the serum of patients with liver disease].
    Rosenmund A
    Schweiz Med Wochenschr; 1971 Jul; 101(28):1023-6. PubMed ID: 5003908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.